Future therapeutic directions in reverse cholesterol transport

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Molecular Biology

Background:

• High-density lipoprotein (HDL) cholesterol levels inversely correlate with atherosclerotic cardiovascular disease (ASCVD).
• Pharmacologic enhancement of HDL metabolism for ASCVD therapy has faced challenges.
• Static HDL levels may not accurately reflect HDL functionality in reverse cholesterol transport (RCT).

Purpose of the Study:

• To review the importance of quantifying RCT flux.
• To discuss current strategies for measuring RCT.
• To highlight therapeutic approaches for augmenting macrophage RCT.

Main Methods:

• Review of current literature on RCT mechanisms and quantification.
• Analysis of molecular underpinnings of cholesterol efflux and transport.
• Discussion of therapeutic strategies targeting macrophage RCT.

Main Results:

• RCT is the process of returning excess cellular cholesterol to the liver for excretion.
• Quantifying RCT flux is critical for assessing therapeutic efficacy.
• Multiple strategies exist to enhance macrophage RCT.

Conclusions:

• Assessing HDL functionality via RCT flux is vital for effective ASCVD therapies.
• Therapeutic strategies focus on improving cholesterol efflux, HDL acceptor function, and hepatic excretion.
• Further research into RCT mechanisms can guide novel treatment development.